| Remdesivir and three other drugs for hospitalised patients with COVID-19: final results of the WHO Solidarity randomised trial and updated meta-analyses H Pan, R Peto, AMH Restrepo, MP Preziosi, V Sathiyamoorthy, QA Karim, ... The Lancet 399 (10339), 1941-1953, 2022 | 288 | 2022 |
| Nifurtimox versus benznidazole or placebo for asymptomatic Trypanosoma cruzi infection (Equivalence of Usual Interventions for Trypanosomiasis - EQUITY … JC Villar, VM Herrera, JG Pérez Carreño, E Váquiro Herrera, ... Trials 20, 1-10, 2019 | 31 | 2019 |
| Chagas disease-related mortality in Colombia from 1979 to 2018: temporal and spatial trends. MJ Olivera, JF Porras-Villamil, JC Villar, EV Herrera, G Buitrago Revista da Sociedade Brasileira de Medicina Tropical 54, e0768-2020, 2021 | 18 | 2021 |
| Efficacy of three benznidazole dosing strategies for adults living with chronic Chagas disease (MULTIBENZ): an international, randomised, double-blind, phase 2b trial P Bosch-Nicolau, ML Fernández, E Sulleiro, JC Villar, JA Perez-Molina, ... The Lancet Infectious Diseases 24 (4), 386-394, 2024 | 14 | 2024 |
| Correction to: Nifurtimox versus benznidazole or placebo for asymptomatic Trypanosoma cruzi infection (Equivalence of Usual Interventions for Trypanosomiasis-EQUITY): study … JC Villar, VM Herrera, JGP Carreño, EV Herrera, YZC Domínguez, ... Trials 20, 2019 | 4 | 2019 |
| SARS-CoV-2 seroprevalence in workers from a Colombian University Hospital K Moreno-Medina, LD Sáenz Pérez, JC Villar, E Váquiro Herrera, ... Occupational Medicine 73 (3), 128-132, 2023 | 2 | 2023 |
| ONE-YEAR EFFICACY OF BENZNIDAZOLE OR NIFURTIMOX AMONG ASYMPTOMATIC TRYPANOSOMA CRUZI SEROPOSITIVE IN COLOMBIA: A PLACEBO-CONTROLLED RANDOMIZED TRIAL JC Villar, E Vaquiro-Herrera, SM Vasquez, VM Herrera, MJ Olivera, ... AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE 105 (5), 146-146, 2021 | 1 | 2021 |
| randomized, double-blinded, phase 2 trial of different dosing strategies for the treatment of adults living with chronic Chagas disease: The MULTIBENZ study P Bosch-Nicolau, M Fernandez, JC Villar, A Ribeiro, E Sulleiro, ... TROPICAL MEDICINE & INTERNATIONAL HEALTH 28, 126-127, 2023 | | 2023 |
| Correction to: Nifurtimox versus benznidazole or placebo for asymptomatic Trypanosoma cruzi infection (Equivalence of Usual Interventions for Trypanosomiasis-EQUITY): study … J Carlos Villar, VM Herrera, JG Perez Carreno, E Vaquiro Herrera, ... BioMed Central, 2019 | | 2019 |
| CORRECTION Open Access JC Villar, VM Herrera, JGP Carreño, EV Herrera, YZC Domínguez, ... | | 2019 |
| Major Article MJ Olivera, JF Porras-Villamil, JC Villar, EV Herrera, G Buitrago | | |
